Benzinga | Mar 25, 2021 08:06AM EDT

Akebia Therapeutics Announces Poster Presentations And Educational Symposium At National Kidney Foundation 2021 Virtual Spring Clinical Meeting Apr. 6-10

Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present data at the National Kidney Foundation 2021 Spring Clinical Meetings (NKF SCM21), which takes place virtually April 6-10, 2021.